Gelonghui May 16 丨 Baiyun Mountain (600332)(00874galagapartycade.HK) announced that on May 15, 2024, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.(hereinafter referred to as "Baiyunshan Hanfang"), a subsidiary of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.(hereinafter referred to as the "Company"), medicinal excipients egg yolk lecithin (for injection) and sodium oleate (for injection) were jointly reviewed by the Center for Drug Evaluation of the State Food Administration (hereinafter referred to as "CDE").
This time, the above-mentioned pharmaceutical excipients have passed the joint review, indicating that they have met relevant national technical standards for drug review and can be produced and sold, which will further enrich the company.galagapartycadeOur product line expands the company's business areas and enhances the company's competitiveness. Due to the characteristics of the pharmaceutical product industry, the production and sales of drugs are subject to changes in the market environment and other factors, and there are uncertainties. Investors are advised to make careful decisions and pay attention to preventing investment risks.
(galagapartycade: Congratulations